Characterization of a Dual-Self Potentiating Pyrazinamide Analog, Morphazinamide

Sequencing data pertaining to the characterization of Morphazinamide as an anti-tubercular therapeutic. The aims of this study are to demonstrate in vitro efficacy of Morphazinamide as an anti-tubercular therapeutic and describe the mode of action in Mycobacterium tuberculosis. Sequencing data in this project contain RNA-Seq data, Tn-Seq data, and whole-genome sequencing of Morphazinamide resistant mutants.